# Premature Neuroimmune and Redox-Inflammatory Breakdown at the Prodromal Stage in Male and Female Triple-Transgenic Alzheimer’s Disease Mice

**Authors:** Lydia Giménez-Llort, Carmen Vida, Judith Félix, Silvia Quer-Palomas, Rashed Manassra, Monica De la Fuente

PMC · DOI: 10.3390/diseases14020061 · Diseases · 2026-02-09

## TL;DR

This study shows that early signs of Alzheimer’s disease include immune and stress-related changes in mice, which may help detect the disease earlier and guide sex-specific treatments.

## Contribution

The study reveals sex-specific neuroimmune and redox-inflammatory breakdowns at the prodromal stage of Alzheimer’s disease in mice.

## Key findings

- 3xTg-AD mice showed anxiety-like behaviors and impaired immune functions like chemotaxis and lymphoproliferation.
- Elevated pro-inflammatory cytokines and oxidative stress were observed in 3xTg-AD mice compared to controls.
- Males exhibited more severe immune and redox dysfunctions than females at the prodromal stage.

## Abstract

Background/Objectives: Homeostatic (nervous, immune and endocrine) systems and their communications network are crucial for health and aging rate. We previously reported behavioral and peritoneal leukocyte function alterations and oxidative-inflammatory stress in young female triple-transgenic (3xTg) mice for Alzheimer’s disease (AD). Here, the deterioration of the homeostatic systems and their interplay was investigated, in an integrated way, at prodromal stages and in both sexes of 3xTg-AD mice. Methods: An integrative analysis of the behavioral profile, peripheral immune splenic and thymic leukocyte functions, splenic oxidative-inflammatory state, and plasmatic corticosterone in both sexes of 3xTg-AD mice at 4 months of age was compared to that of age- and sex-matched NTg counterparts. Results: The prodromal stage of 3xTg-AD, characterized by anxiety-like behaviors and disrupted exploration, was aligned with reduced chemotaxis, natural killer activity, and lymphoproliferation—especially in the spleen. In addition, 3xTg-AD mice exhibited lower anti-inflammatory (IL-10) and higher pro-inflammatory (IL-2, IL-1β, and TNF-α) cytokine concentrations and oxidative stress (higher oxidants and lower antioxidants). Several of these alterations displayed sex-dependent differences (worse in males). However, no differences in corticosterone were found. Conclusions: These findings suggest that neuroimmune and redox-inflammatory dysfunctions, indicative of premature aging, emerge at the prodromal stage of AD, preceding corticosterone changes, unveiling a time lag in the neuroimmunoendocrine alterations in these animals. They may act as early indicators of premature aging in AD pathology and provide potential targets for sex-specific prodromal intervention.

## Linked entities

- **Proteins:** IL10 (interleukin 10), IL2 (interleukin 2), IL1B (interleukin 1 beta), TNF (tumor necrosis factor)
- **Diseases:** Alzheimer’s disease (MONDO:0004975)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Prdx6-ps2 (peroxiredoxin 6 pseudogene 2) [NCBI Gene 384001] {aka Aop2-rs2, GPx*, Prdx6-rs2}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Xdh (xanthine dehydrogenase) [NCBI Gene 22436] {aka XO, Xor, Xox-1, Xox1}, Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, Nr3c1 (nuclear receptor subfamily 3, group C, member 1) [NCBI Gene 14815] {aka GR, Grl-1, Grl1}, Alb (albumin) [NCBI Gene 11657] {aka Alb-1, Alb1, BCL001, BCL002, BPL001}, Gsr (glutathione reductase) [NCBI Gene 14782] {aka D8Ertd238e, Gr-1, Gr1}, App (amyloid beta precursor protein) [NCBI Gene 11820] {aka Abeta, Abpp, Adap, Ag, Cvap, E030013M08Rik}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Il1 (interleukin 1 complex) [NCBI Gene 111343] {aka Il-1}, Il2 (interleukin 2) [NCBI Gene 16183] {aka Il-2}, Tnfsf10 (tumor necrosis factor (ligand) superfamily, member 10) [NCBI Gene 22035] {aka A330042I21Rik, APO-2L, Ly81, TL2, Tnlg6a, Trail}
- **Diseases:** neurodegenerative disease (MESH:D019636), injury to (MESH:D014947), Inflammatory (MESH:D007249), gliosis (MESH:D005911), Cytotoxicity (MESH:D064420), anxiety (MESH:D001007), neuroinflammation (MESH:D000090862), behavioral disturbances (MESH:D001523), AD (MESH:D000544), Impairment (MESH:D060825), immune dysfunction (MESH:D007154), adrenal hypertrophy (MESH:D006984), tumor (MESH:D009369), splenic (MESH:D013158), amyloid (MESH:C000718787), dementia (MESH:D003704), overweight (MESH:D050177), parasitic infection (MESH:D010272), neophobia (MESH:D000080146), neuronal loss (MESH:D009410), lymphoma (MESH:D008223), autoimmunity (MESH:D001327), splenomegaly (MESH:D013163), Killer (MESH:D000077428), cognitive decline (MESH:D003072), neuropathological (MESH:D009422), cholinergic deficits (MESH:C535672), frailty (MESH:D000073496), neurological disorder (MESH:D009461), adrenal glands (MESH:D000307)
- **Chemicals:** phosphate (MESH:D010710), H2O2 (MESH:D006861), 3H-thymidine (-), superoxide (MESH:D013481), Trypan-Blue (MESH:D014343), phenol red (MESH:D010637), Thymidine (MESH:D013936), GSSG (MESH:D019803), TCA (MESH:D014238), Corticosterone (MESH:D003345), resorufin (MESH:C014180), f-met-leu-phe (MESH:D009240), uric acid (MESH:D014527), EDTA (MESH:D004492), urea (MESH:D014508), LPS (MESH:D008070), lipid (MESH:D008055), purine (MESH:C030985), tetrazolium salts (MESH:D013778), CO2 (MESH:D002245), Amplex Red reagent (MESH:C470430), GSH (MESH:D005978), L-glutamine (MESH:D005973), bicinchoninic acid (MESH:C047117), xanthine (MESH:D019820), cumene hydroperoxide (MESH:C007164), 5,5'-dithiobis-(2-nitrobenzoic acid) (MESH:D004228), gentamicin (MESH:D005839), HCl (MESH:D006851)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** P301L
- **Cell lines:** YAC-1 — Mus musculus (Mouse), Mouse lymphoma, Cancer cell line (CVCL_2244), 3xTg-AD — Homo sapiens (Human), Alzheimer's disease, Transformed cell line (CVCL_RN76)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12939257/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12939257/full.md

## References

76 references — full list in the complete paper: https://tomesphere.com/paper/PMC12939257/full.md

---
Source: https://tomesphere.com/paper/PMC12939257